Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Vitamin D is needed for metformin to lower prolactin effectively.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

Elagolix did not effectively treat polycystic ovary syndrome.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Deslorelin implant successfully regrew hair in a female Pomeranian with alopecia X.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.